Sarah Tuller

Sarah Tuller, J.D, RAC has extensive experience in regulatory affairs, with a focus on cell therapy/regenerative medicine and mitochondrial dysfunction portfolios. Sarah has held leadership positions in various pharmaceutical companies, including Tenpoint Therapeutics Ltd as Chief Regulatory Officer, Opus Genetics as Chief Regulatory Officer and Vice President of Regulatory Affairs and Medical Writing, and Astellas Pharma US as a Senior Director of Regulatory Affairs and RA Medical Specialties Team Lead. Sarah has also worked as a Senior Director of Regulatory Affairs at Retrophin, Director of Regulatory Affairs at aTyr Pharma, and Director of Regulatory Affairs at Voisin Consulting Life Sciences. Sarah's expertise and experience make their a highly skilled and knowledgeable professional in the field of regulatory affairs.

Sarah Tuller earned a Juris Doctorate (JD) degree in Patent Law from the University of Dayton School of Law. Sarah also obtained certifications from the Ohio State Bar Association and the Regulatory Affairs Professionals Society (RAPS), including the Regulatory Affairs Certification (RAC).